公司新闻
更多>>公司公告
更多>>- 01/02SHIELD THERAPEUTICS PLC--Block listing 6 Monthly Return
- 01/02SHIELD THERAPEUTICS PLC--Total Voting Rights
- 12/18SHIELD THERAPEUTICS PLC--Block Listing Application
- 12/11SHIELD THERAPEUTICS PLC--Shield Wins Gold at Titan Branding Awards
- 11/14SHIELD THERAPEUTICS PLC--Initiation of a Phase II Clinical Trial in Japan
- 11/11SHIELD THERAPEUTICS PLC--ACCRUFeR Pediatric PK Results to be Presented
- 11/07SHIELD THERAPEUTICS PLC--ACCRUFeR receives Authorisation by Korean Ministry
- 10/23Shield Therapeutics PLC--Q3 2025 Trading Update
- 10/01Shield Therapeutics PLC--Total Voting Rights
- 10/01Shield Therapeutics PLC--Positive efficacy and tolerance in pediatric trial
- 09/03Shield Therapeutics PLC--Interim results for the six months ended 30 Jun 25
- 08/27Shield Therapeutics PLC--Data published -European Journal of Heart Failure
- 08/21Shield Therapeutics PLC--Interim results for the six months ended 30 Jun 25
- 07/23Shield Therapeutics PLC--Q2 2025 Trading Update